ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,529, issued on Jan. 27, was assigned to Solve Therapeutics Inc. (San Diego).
"PTK7-binding proteins" was invented by Jeffry D. Watkins (Encinitas, Calif.), Andrew Pow (Encinitas, Calif.), Brian Lannutti (Solana Beach, Calif.) and Katti Jessen (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides recombinant proteins that bind to PTK7 and methods of using them to treat cancer."
The patent was filed on April 10, 2025, under Application No. 19/175,619.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPT...